Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Novel PIONEER© Protocol: RCT

Study ID: NCT07035912
Start Date: 2026-07-01
End Date: 2032-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

134

Intervention / Treatment

PIONEER Protocol

Sponsor

Nationwide Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Ultrasound Assessment of Achilles Tendon-Neurovascular Distance in Infants With Unilateral Clubfoot

Study ID: NCT07473908
Start Date: 2026-05-01
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

ultrasound

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Study ID: NCT07458347
Start Date: 2026-04
End Date: 2028-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

145

Intervention / Treatment

KST-6051

Sponsor

Kestrel Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Vancomycin Taper to Prevent Recurrent Clostridioides Difficile

Study ID: NCT07328971
Start Date: 2026-06-01
End Date: 2030-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

500

Intervention / Treatment

Fidaxomicin

Vancomycin capsule

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Source: clinicaltrials.gov

Share:
Add to list

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Study ID: NCT06954987
Start Date: 2026-07-17
End Date: 2028-05-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

244

Intervention / Treatment

Allogeneic Hematopoietic Stem Cell Transplantation

Biospecimen Collection

Bone Marrow Biopsy

Busulfan

Chest Radiography

Computed Tomography

Echocardiography Test

Fludarabine

Melphalan

Multigated Acquisition Scan

Placebo Administration

Positron Emission Tomography

Total-Body Irradiation

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Study ID: NCT07455006
Start Date: 2026-04-20
End Date: 2028-03-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

60

Intervention / Treatment

QL0911

Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Utility of a Mobile Application for Young Women With Breast Cancer

Study ID: NCT07009093
Start Date: 2026-04
End Date: 2030-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Mighty Pro Application

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Vitamin D and Type 2 Diabetes - Treat-To-Target

Study ID: NCT07448974
Start Date: 2026-05
End Date: 2031-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

100

Intervention / Treatment

Vitamin D (Cholecalciferol )

Placebo

Sponsor

Tufts Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

Study ID: NCT07432490
Start Date: 2026-05
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

L-fucose

Placebo

Sponsor

Oregon Health and Science University

Source: clinicaltrials.gov

Share:
Add to list

Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

Study ID: NCT07467213
Start Date: 2026-04-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

5000

Intervention / Treatment

Overwhelmed

Proton Pump Inhibitors (PPI)

Sponsor

Samsung Medical Center

Source: clinicaltrials.gov

Share:
Add to list